Ralph Pries

Tumour‐derived prostaglandin E₂and transforming growth factor‐β synergize to inhibit plasmacytoid dendritic cell‐derived interferon‐α

Isabelle Bekeredjian‐Ding, Meike Schäfer, Evelyn Hartmann et al. · Immunology · 2009 · 101 citations · Full text

Life Sciences, Immunology, Oncology +17

Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development

Rebecca Kesselring, Andreas Thiel, Ralph Pries et al. · British Journal of Cancer · 2010 · 91 citations · Full text

Medicine, Immunology, Oncology +11

PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy

Verena Rolfes, Christian Idel, Ralph Pries et al. · Oncotarget · 2018 · 88 citations · Full text

Life Sciences, Immunology, Oncology +14

The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack

Rebecca Kesselring, Annette Thiel, Ralph Pries et al. · European Journal of Cancer · 2014 · 68 citations

Medicine, Immunology, Oncology +15

Decline of Lactate in Tumor Tissue After Ketogenic Diet: In Vivo Microdialysis Study in Patients with Head and Neck Cancer

Ursula C. Schroeder, Bastian Himpe, Ralph Pries et al. · Nutrition and Cancer · 2013 · 67 citations

Life Sciences, Biochemistry, Oncology +17